Eighteen months ago a federal facilities solicitation said one thing. Today the same buyer's specs say something else. The transformation already happened. Almost nobody noticed.
The contracting officer's pickup truck could have held everyone who noticed. A facilities solicitation eighteen months back got three new lines under acceptable materials and two old ones struck through — the kind of edit a careful reader catches and a busy reader misses. The careful readers were rare. The language changed; the categories shifted; the performance bars moved. The transformation happened in the document, on a Tuesday, in a font nobody finds beautiful. The press will get to it in a few years.
There is a thing nobody mentions about industrial transformation, which is that the announcement comes a few years after the transformation. The trade press is waiting on EPA. The ESG circuit is waiting on a disclosure framework. Climate Twitter is waiting on a consumer brand it can quote-retweet. Meanwhile a quieter set of people — the ones who write solicitations, the ones who revise specs, the ones who sign awards — have been rewiring the floor of the regenerative economy for the better part of a decade. They were not asked their opinion, and they did not offer one. They simply changed what gets ordered, and the rest of us are catching up.
I.
When people talk about the supply chain for the regenerative economy, they tend to mean one of two things. They mean Whole Foods — the consumer end, where a biobased product gets a green label and a story about a family farm. Or they mean ESG disclosure — the accountant's end, where a company writes down what's in its inputs and a fund manager grades the homework.
Neither of those is what I mean.
What I mean is the part in between. The actual material flow: who makes the biobased polymer, who hauls the fluorine-free foam, who specifies the recycled aggregate, who supplies the plant-derived solvent in industrial volume. The middle layer nobody photographs, because there is nothing to photograph but a warehouse and a spec sheet.
That middle layer has a buy-side, and the buy-side is the United States federal government. Washington spends something north of $700 billion a year on goods and services, and the rules about what it can prefer — what it must prefer — have been shifting category by category since the 2002 Farm Bill put the BioPreferred Program into 7 U.S.C. § 8102. Most of that shift has happened without a press cycle. Section 322 of the FY2020 National Defense Authorization Act told the Department of Defense to stop buying firefighting foam that contains PFAS by October 1, 2023, and to stop using it on installations by October 1, 2024. The 2024 Sustainable Procurement rule moved the biobased preference into FAR 23.107-2 and the reporting clause into FAR 52.223-2. None of these were front-page stories. All of them changed what gets ordered.
The manufacturers responding to those orders are the supply chain I mean.
II.
The easiest way to see this is to walk through it category by category. Each one is a story about a regulatory hook, a manufacturer that showed up to meet it, and a piece of the regenerative economy that exists now in a way it didn't five years ago. None of these stories is going to make a magazine cover. Together they are most of the action.
Fluorine-free firefighting foam. For seventy years the military's firefighting agent of choice was a compound it now turns out should not have been anyone's choice. AFFF — aqueous film-forming foam — put out jet-fuel fires beautifully and contaminated the groundwater under every base it was sprayed at. In 2019, Congress had had enough. Section 322 of the FY2020 National Defense Authorization Act told the Department of Defense to stop buying AFFF that contains PFAS by October 1, 2023, and to stop using it on installations by October 1, 2024. In January 2023, the Defense Logistics Agency published MIL-PRF-32725 — the performance spec for the replacement, a fluorine-free foam that has to put out a JP-5 fire in thirty seconds without poisoning the watershed. There is now a procurement category that did not exist three years ago, and the manufacturers in it have started raising serious capital.
Biobased polymers in federal facilities. The BioPreferred Program is the workhorse nobody knows about. Established by the 2002 Farm Bill under 7 U.S.C. § 8102, administered by USDA, it identifies categories of biobased products — everything from lubricants to carpet adhesives to insulation foams — and tells federal agencies they have to give preference to certified products in those categories. The 2024 Sustainable Procurement final rule consolidated the rules at FAR 23.107-2 and put the reporting clause in every applicable contract at FAR 52.223-2. The designated-category list runs to more than a hundred. What that means in practice: a GSA building manager replacing a carpet, an Army base ordering hydraulic fluid, a Navy facility specifying paint — each of them sits inside a procurement framework that prefers the biobased version of the product. The preference does not always win. But it has to be considered, and twenty years of "has to be considered" turns into a market.
Plant-derived solvents and cleaners. The same logic runs through the cleaning closet. In August 2024, the EPA strengthened its Safer Choice Standard — the criteria a product has to meet to earn the Safer Choice label, anchored in TSCA and the Pollution Prevention Act. The new standard added an outdoor-use label, tightened ingredient screening, and put pressure on the conventional surfactant and solvent chemistry that has dominated industrial cleaning for fifty years. There are now about two thousand labeled products on the market. That number sounds small until you remember what it represents: every gallon of plant-derived degreaser that earns the label is a gallon of petroleum-derived degreaser that did not get bought. The substitution is happening one SKU at a time, in places nobody writes profiles about — janitorial supply distributors, industrial facility procurement teams, mid-size manufacturers reformulating because their customer's specs changed.
Bamboo, hemp, mycelium. The categories that get the press — bamboo composites, hemp insulation, mycelium-grown packaging — are real and growing, but the press version is misleading. The interesting part is not that a startup grew a mushroom-based shipping container. The interesting part is that there is a BioPreferred designated category for that container, which means a federal buyer comparing options is operating under a procurement preference that did not exist twenty years ago. The fashionable end of the regenerative economy and the unfashionable end share a buy-side. This is the trick of federal procurement: it doesn't pick winners, but it does enlarge the field. A material that would otherwise be a curiosity becomes a category. A category eventually becomes a line item. A line item eventually becomes a market.
III.
The question worth asking is why this transformation, which has been visible to anyone who reads federal solicitations for ten years, is not visible in the conversation about the climate transition. There are four honest reasons.
The first is that the trade press covers announcements, not implementation. A regulation getting passed is a story. A contracting officer revising a spec six months later to reflect the regulation is not a story, because nothing happened that day except a document was updated. So the regulation gets a headline, the spec revision does not, and the actual change disappears into the silence between one announcement and the next.
The second is that the ESG conversation is shaped like a financial disclosure. It tracks what a company says about its inputs — its Scope 3 emissions, its sustainability report, its ratings letter. It does not track what gets ordered. By the time the material flow shows up in the disclosure, the order was placed two quarters ago and the decision that mattered was made by a procurement team the ratings analyst will never speak to. The disclosure layer sits downstream of every interesting moment.
The third is that the consumer-facing climate narrative wants a consumer-facing story. A bamboo toothbrush is photographable. A fluorine-free firefighting foam being adopted at Camp Pendleton is not. So the regenerative economy gets reported as a parade of charming small objects, and the part that is actually moving billions of dollars of material — the federal middle layer — goes uncovered because it doesn't shoot well.
The fourth reason is the simplest. The vantage point that lets you see this is unusual. To see it, you have to read solicitations. You have to track BioPreferred category designations. You have to follow what the Defense Logistics Agency publishes. You have to know what FAR 23.107-2 means without looking it up. Almost nobody whose job description includes covering the climate transition does any of those things. And the people who do do them — the manufacturers and the contracting officers — are too busy doing the work to also write about it.
Which leaves the field, more or less, to anyone who happens to be standing in the right spot and willing to point.
IV.
The honest reason any of this matters is that it changes what is possible.
When federal procurement starts preferring a category of product across a hundred and fifty thousand contracts a year, the substitution stops being symbolic and starts being structural. A pilot project — a single Army base trying a new foam, a single GSA building swapping a single carpet — proves that a thing can be done. It does not reroute material flows. A statutory preference, applied across categories, at seven hundred billion dollars a year of buying volume, does. The thing about a pilot project is that nobody has to refinance their plant to make it. The thing about a procurement preference that compounds for two decades is that everyone does.
It also makes possible a kind of manufacturer that capital markets generally do not finance. You cannot put fluorine-free firefighting foam on a shelf at Whole Foods. You cannot sell industrial hydraulic fluid through a direct-to-consumer brand. There are categories of biobased chemistry that are essential and unphotographable, and the only way they get built at scale is if there is a buyer for them that does not require a brand. The federal government is that buyer. Without it, the chemistry gets invented and never scaled. With it, the chemistry has a runway long enough to find a price curve.
It opens an on-ramp for small businesses that the venture path does not. A small manufacturer building a biobased product can sit inside multiple federal procurement preferences at once — BioPreferred for the product, SDVOSB or HUBZone or 8(a) for the firm — and each preference reinforces the others. The on-ramp is real, and the people who walk up it are mostly people the technology press has never heard of: family-owned chemical companies in the Midwest, veteran-owned firms in places without a startup scene, small manufacturers with two-decade product roadmaps and no patience for an investor deck.
And it is a climate lever that survives administrations. ESG is downstream of a regulatory fashion that can change. Voluntary corporate commitments are downstream of a CEO who can be replaced. But the BioPreferred Program lives in 7 U.S.C. § 8102. The AFFF phase-out lives in Section 322 of an NDAA that passed with overwhelming bipartisan support. The biobased preference lives in FAR 23.107-2. The laws that govern what the federal government can buy are older and quieter than the laws that govern what it can announce, and they outlast the news cycle by a wide margin.
V.
I am writing this from inside one of the small companies that watches federal procurement closely, which is to say, from inside the unphotographed middle layer the rest of this essay was about. The view from here is different from the view in the trade press, which is part of why I wrote it. Most of the people in the position I am in are too busy filling specs to publish, which is a kind of luck for whoever does.
If you make something the federal government has started preferring, or could start preferring, the transformation described above is not abstract for you. It is a list of solicitations you should already be reading. If you specify what the federal government buys, it is a list of categories where the preferred option is closer to ready than it used to be.
There is nothing being announced. There is only what is being ordered.
The capital behind it. None of this would matter if there were nothing to buy. The manufacturers showing up to fill these specs need plants, equipment, fermentation tanks, extraction lines. Building that takes money. In 2022, the Inflation Reduction Act put five hundred million dollars into USDA's Section 9003 program — the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program — to back loan guarantees of up to $250 million per project. The money is available through fiscal year 2031. This is the unglamorous capital stack behind the unglamorous supply chain: not the venture rounds with the press releases, but the federal loan guarantees that let a biorefinery break ground in a county nobody can pronounce.
